Randy Meier

Currently holds a position at Biomarin Pharmaceutical Inc

2.1

2.1

Position	Company	Period
Lead Independent Director	Biomarin Pharmaceutical Inc	Jan. 1, 2015 -
Chief Financial Officer, Executive Vice President, President - International	Accendra Health Inc	July 1, 2015 - May 31, 2018
Independent Director	STAAR Surgical Co	June 25, 2009 - June 24, 2016
Chief Financial Officer, Executive Vice President	Accendra Health Inc	March 1, 2013 - July 1, 2015
Independent Director	Biomarin Pharmaceutical Inc	Dec. 14, 2006 - Jan. 1, 2015
Chief Financial Officer, Executive Vice President	Teleflex Inc	Jan. 11, 2010 - March 9, 2012

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-05-04	2022-05-02	Biomarin Pharmaceutical Inc (BMRN)	S Sale	37,539 +14.7% 329.99 US$1,446,205	37,539 +14.7%	329.99	US$1,446,205
2022-05-04	2022-05-02	Biomarin Pharmaceutical Inc (BMRN)	S Sale	93,406 -37.6% 180.08 US$2,207,476	93,406 -37.6%	180.08	US$2,207,476
2021-05-07	2021-05-06	Biomarin Pharmaceutical Inc (BMRN)	S Sale	51,100 -40.9% 188.73 US$1,805,694	51,100 -40.9%	188.73	US$1,805,694
2020-03-17	2020-03-17	Intersect Ent Inc (XENT)	B Purchase	5,000 +4.2% 7.80 US$38,997	5,000 +4.2%	7.80	US$38,997
2020-03-17	2020-03-16	Intersect Ent Inc (XENT)	B Purchase	2,500 +2.1% 13.75 US$34,375	2,500 +2.1%	13.75	US$34,375
2020-03-17	2020-03-16	Intersect Ent Inc (XENT)	B Purchase	2,500 +2.2% 13.50 US$33,750	2,500 +2.2%	13.50	US$33,750
2020-03-17	2020-03-16	Intersect Ent Inc (XENT)	B Purchase	2,500 +2.2% 12.75 US$31,875	2,500 +2.2%	12.75	US$31,875
2020-03-17	2020-03-16	Intersect Ent Inc (XENT)	B Purchase	2,500 +2.3% 10.19 US$25,462	2,500 +2.3%	10.19	US$25,462